ADVENZYMES

NSE

Advanced Enzyme Technologies Limited

₹291.15-1.60 (-0.55%)Close, 25 Sept 2026

Key statistics

Open: ₹292.75
Day range: 290.00 – 297.00
52-week range: 251.95 – 419.00
From 52w high: -30.5%
Volume: 1.86L
Turnover: ₹5.4Cr
Delivery: 61.0%
Rel volume: 0.86×
RSI (14): 42.3
ATR (14): 8.44
SMA 50: 303.98
SMA 200: 313.36

Performance

1 day: -0.55%
1 week: +1.16%
1 month: -2.04%
3 months: -9.33%
6 months: +9.13%
1 year: -14.38%

Delivery percentage

Latest: 61.0%
20-day avg: 58.5%
1-year avg: 53.7%
Percentile: 84th
Range: 8.3–95.5%

Over the last 20 sessions ADVENZYMES settled 58.5% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.7%, so recent sessions are running 4.8 points higher than usual. The latest session ranks higher than 84% of the 1,725 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

Fundamentals

Market cap: ₹3,260 Cr
P/E (TTM): 18.98
EPS (TTM): ₹15.34
Shares outstanding: 11.20Cr
Listed: 1 Aug 2016

Classification

Macro sector: Healthcare
Sector: Healthcare
Industry: Pharmaceuticals & Biotechnology
Basic industry: Biotechnology

NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.

Growthlatest filed quarter Q1 FY27

Revenue YoY: +2.08%
Profit YoY: -4.58%
Revenue QoQ: -6.68%
Profit QoQ: -14.72%
Interest cost YoY: —

Compound growth

Not enough filed history for a compound growth rate yet.

Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.

About

ISIN: INE837H01020
Series: EQ
History from: 1 Aug 2016
Sessions: 2,513

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.